Atlas Trials

Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer

Clinical trial NCT03922776 · TERMINATED

Trial details

NCT number
NCT03922776
Sponsor
Centre Oscar Lambret
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Ovarian Cancer Stage IIICFallopian Tube Cancer Stage IIICFallopian Tube Cancer Stage IVOvarian Cancer Stage IV
Start date
2019-05-17
Primary completion
2024-05-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.